lung cancer vaccination (2010-5-18)
DMC recommends Celsion to continue enrollment in ThermoDox clinical study for primary liver cancer
Celsion Corporation announced today that after reviewing data from 294 patients including data from 12 Japanese patients enrolled in the pivotal Phase III ThermoDox® clinical study (HEAT Study) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue [...]
